Sapropterin Dihydrochloride Powder, For Solution
Product Images NDC 52817-850
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Sapropterin Dihydrochloride (NDC 52817-850). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Trupharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image Description (Sapropterin Dihydrochloride 100mg Container Label)
Image Description (Sapropterin Dihydrochloride 500mg Carton Label)
Image Description (Sapropterin Dihydrochloride 500mg Container Label)
Image Description (Sapropterin Dihydrochloride Figure 1)
Image Description (Sapropterin Dihydrochloride Figure 2)
Image Description (Sapropterin Dihydrochloride Figure 3)
Image Description (Sapropterin Dihydrochloride Figure 4)
Image Description (Sapropterin Dihydrochloride Figure 5)
Image Description (Sapropterin Dihydrochloride Figure 6)
Image Description (Sapropterin Dihydrochloride Figure 7)
Image Description (Sapropterin Dihydrochloride Graph 2)
Image Description (Sapropterin Dihydrochloride Graph)
This text appears to be a table displaying Blood Phe Level (µmol/L) readings at different time points. The target Blood Phe Control Range is not explicitly stated. The table seems to be related to blood phenylalanine levels for different age groups, possibly children, indicated as "1 month to <2 years" and "2 to <7 years". The text also mentions a study visit.*
Image Description (Sapropterin Dihydrochloride Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.